APO Research
Talk to an analyst

APO RESEARCH · REPORT

Genetic Screening for Carrier Diseases

Compare research editions
View pricing & licenses

Selected research

Industry Research

Genetic Screening for Carrier Diseases Industry Research Report 2026

1 January 2026139 pages

Choose your research edition.

Industry ResearchGenetic Screening for Carrier Diseases Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Genetic Screening for Carrier Diseases Industry Growth and Trends Forecast to 2032123 pages · $3,450 USDMarket StructureGlobal Genetic Screening for Carrier Diseases Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Genetic Screening for Carrier Diseases Market Outlook and Growth Opportunities 2026217 pages · $4,250 USDMarket Analysis & ForecastGlobal Genetic Screening for Carrier Diseases Market Analysis and Forecast 2026-2032213 pages · $4,950 USD

Market perspective

The global Genetic Screening for Carrier Diseases market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

North America: the Genetic Screening for Carrier Diseases market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Genetic Screening for Carrier Diseases market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Genetic Screening for Carrier Diseases market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Genetic Screening for Carrier Diseases include Thermo Fisher Scientific, Eurofins Scientific, Illumina, Invitae, MedGenome, Myriad Genetics, Roche, Natera and OPKO Health, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

Read the full market overview

This report quantifies the global Genetic Screening for Carrier Diseases market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Genetic Screening for Carrier Diseases.

Key Companies & Market Share Insights

This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Genetic Screening for Carrier Diseases Market by Company

Thermo Fisher Scientific

Eurofins Scientific

Illumina

Invitae

MedGenome

Myriad Genetics

Roche

Natera

OPKO Health

23andMe

bioMérieux

EKF Diagnostics

Gene by Gene (myDNA)

Fulgent Genetics

NxGen MDx

Sonic Genetics

My Baby

AncestryDNA

DiaSorin

Grifols

BGI Genomics

Chigene

Jiajian Medical Testing

Genesky

Berry Genomics

Weihansi Biomedical Technology

Annaroad

Genetic Screening for Carrier Diseases Segment by Type

NGS

Whole Exome Sequencing

Others

Genetic Screening for Carrier Diseases Segment by Application

Couple

Individual

Genetic Screening for Carrier Diseases Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Spain

Russia

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Saudi Arabia

Israel

United Arab Emirates

Turkey

Iran

Egypt

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Genetic Screening for Carrier Diseases market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Genetic Screening for Carrier Diseases and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Genetic Screening for Carrier Diseases.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 6: Detailed analysis of Genetic Screening for Carrier Diseases companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 13: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Genetic Screening for Carrier Diseases Market Size by Type (2021-2026) & (US$ Million) Table 6. Global Genetic Screening for Carrier Diseases Revenue Market Share by Type (2021-2026) Table 7. Global Genetic Screening for Carrier Diseases Forecasted Market Size by Type (2027-2032) & (US$ Million) Table 8. Global Genetic Screening for Carrier Diseases Revenue Market Share by Type (2027-2032) Table 9. Global Genetic Screening for Carrier Diseases Market Size by Application (2021-2026) & (US$ Million) Table 10. Global Genetic Screening for Carrier Diseases Revenue Market Share by Application (2021-2026) Table 11. Global Genetic Screening for Carrier Diseases Forecasted Market Size by Application (2027-2032) & (US$ Million) Table 12. Global Genetic Screening for Carrier Diseases Revenue Market Share by Application (2027-2032) Table 13. Global Genetic Screening for Carrier Diseases Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Genetic Screening for Carrier Diseases Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Genetic Screening for Carrier Diseases Market Share by Region (2021-2026) Table 16. Global Genetic Screening for Carrier Diseases Forecasted Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Genetic Screening for Carrier Diseases Market Share by Region (2027-2032) Table 18. Genetic Screening for Carrier Diseases Industry Trends Table 19. Genetic Screening for Carrier Diseases Industry Drivers Table 20. Genetic Screening for Carrier Diseases Industry Opportunities and Challenges Table 21. Genetic Screening for Carrier Diseases Market Restraints Table 22. Global Top Genetic Screening for Carrier Diseases Players by Revenue (US$ Million) & (2021-2026) Table 23. Global Genetic Screening for Carrier Diseases Revenue Market Share by Players (2021-2026) Table 24. Global Genetic Screening for Carrier Diseases Industry Players Ranking, 2024 VS 2025 VS 2026 Table 25. Global Key Players of Genetic Screening for Carrier Diseases, Headquarters and Area Served Table 26. Global Genetic Screening for Carrier Diseases Players, Product Type & Application Table 27. Global Players Market Concentration Ratio (CR5 and HHI) Table 28. Global Genetic Screening for Carrier Diseases by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 29. Players Mergers & Acquisitions, Expansion Plans Table 30. North America Genetic Screening for Carrier Diseases Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 31. North America Genetic Screening for Carrier Diseases Market Size by Country (2021-2026) & (US$ Million) Table 32. North America Genetic Screening for Carrier Diseases Market Size by Country (2027-2032) & (US$ Million) Table 33. Europe Genetic Screening for Carrier Diseases Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Europe Genetic Screening for Carrier Diseases Market Size by Country (2021-2026) & (US$ Million) Table 35. Europe Genetic Screening for Carrier Diseases Market Size by Country (2027-2032) & (US$ Million) Table 36. Asia Pacific Genetic Screening for Carrier Diseases Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Asia Pacific Genetic Screening for Carrier Diseases Market Size by Region (2021-2026) & (US$ Million) Table 38. Asia Pacific Genetic Screening for Carrier Diseases Market Size by Country (2027-2032) & (US$ Million) Table 39. South America Genetic Screening for Carrier Diseases Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 40. South America Genetic Screening for Carrier Diseases Market Size by Country (2021-2026) & (US$ Million) Table 41. South America Genetic Screening for Carrier Diseases Market Size by Country (2027-2032) & (US$ Million) Table 42. Middle East & Africa Genetic Screening for Carrier Diseases Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 43. Middle East & Africa Genetic Screening for Carrier Diseases Market Size by Country (2021-2026) & (US$ Million) Table 44. Middle East & Africa Genetic Screening for Carrier Diseases Market Size by Country (2027-2032) & (US$ Million) Table 45. Thermo Fisher Scientific Company Information Table 46. Thermo Fisher Scientific Business Overview Table 47. Thermo Fisher Scientific Revenue in Genetic Screening for Carrier Diseases Business (2021-2026) & (US$ Million) Table 48. Thermo Fisher Scientific Genetic Screening for Carrier Diseases Product Portfolio Table 49. Thermo Fisher Scientific Recent Developments Table 50. Eurofins Scientific Company Information Table 51. Eurofins Scientific Business Overview Table 52. Eurofins Scientific Revenue in Genetic Screening for Carrier Diseases Business (2021-2026) & (US$ Million) Table 53. Eurofins Scientific Genetic Screening for Carrier Diseases Product Portfolio Table 54. Eurofins Scientific Recent Developments Table 55. Illumina Company Information Table 56. Illumina Business Overview Table 57. Illumina Revenue in Genetic Screening for Carrier Diseases Business (2021-2026) & (US$ Million) Table 58. Illumina Genetic Screening for Carrier Diseases Product Portfolio Table 59. Illumina Recent Developments Table 60. Invitae Company Information Table 61. Invitae Business Overview Table 62. Invitae Revenue in Genetic Screening for Carrier Diseases Business (2021-2026) & (US$ Million) Table 63. Invitae Genetic Screening for Carrier Diseases Product Portfolio Table 64. Invitae Recent Developments Table 65. MedGenome Company Information Table 66. MedGenome Business Overview Table 67. MedGenome Revenue in Genetic Screening for Carrier Diseases Business (2021-2026) & (US$ Million) Table 68. MedGenome Genetic Screening for Carrier Diseases Product Portfolio Table 69. MedGenome Recent Developments Table 70. Myriad Genetics Company Information Table 71. Myriad Genetics Business Overview Table 72. Myriad Genetics Revenue in Genetic Screening for Carrier Diseases Business (2021-2026) & (US$ Million) Table 73. Myriad Genetics Genetic Screening for Carrier Diseases Product Portfolio Table 74. Myriad Genetics Recent Developments Table 75. Roche Company Information Table 76. Roche Business Overview Table 77. Roche Revenue in Genetic Screening for Carrier Diseases Business (2021-2026) & (US$ Million) Table 78. Roche Genetic Screening for Carrier Diseases Product Portfolio Table 79. Roche Recent Developments Table 80. Natera Company Information Table 81. Natera Business Overview Table 82. Natera Revenue in Genetic Screening for Carrier Diseases Business (2021-2026) & (US$ Million) Table 83. Natera Genetic Screening for Carrier Diseases Product Portfolio Table 84. Natera Recent Developments Table 85. OPKO Health Company Information Table 86. OPKO Health Business Overview Table 87. OPKO Health Revenue in Genetic Screening for Carrier Diseases Business (2021-2026) & (US$ Million) Table 88. OPKO Health Genetic Screening for Carrier Diseases Product Portfolio Table 89. OPKO Health Recent Developments Table 90. 23andMe Company Information Table 91. 23andMe Business Overview Table 92. 23andMe Revenue in Genetic Screening for Carrier Diseases Business (2021-2026) & (US$ Million) Table 93. 23andMe Genetic Screening for Carrier Diseases Product Portfolio Table 94. 23andMe Recent Developments Table 95. bioMérieux Company Information Table 96. bioMérieux Business Overview Table 97. bioMérieux Revenue in Genetic Screening for Carrier Diseases Business (2021-2026) & (US$ Million) Table 98. bioMérieux Genetic Screening for Carrier Diseases Product Portfolio Table 99. bioMérieux Recent Developments Table 100. EKF Diagnostics Company Information Table 101. EKF Diagnostics Business Overview Table 102. EKF Diagnostics Revenue in Genetic Screening for Carrier Diseases Business (2021-2026) & (US$ Million) Table 103. EKF Diagnostics Genetic Screening for Carrier Diseases Product Portfolio Table 104. EKF Diagnostics Recent Developments Table 105. Gene by Gene (myDNA) Company Information Table 106. Gene by Gene (myDNA) Business Overview Table 107. Gene by Gene (myDNA) Revenue in Genetic Screening for Carrier Diseases Business (2021-2026) & (US$ Million) Table 108. Gene by Gene (myDNA) Genetic Screening for Carrier Diseases Product Portfolio Table 109. Gene by Gene (myDNA) Recent Developments Table 110. Fulgent Genetics Company Information Table 111. Fulgent Genetics Business Overview Table 112. Fulgent Genetics Revenue in Genetic Screening for Carrier Diseases Business (2021-2026) & (US$ Million) Table 113. Fulgent Genetics Genetic Screening for Carrier Diseases Product Portfolio Table 114. Fulgent Genetics Recent Developments Table 115. NxGen MDx Company Information Table 116. NxGen MDx Business Overview Table 117. NxGen MDx Revenue in Genetic Screening for Carrier Diseases Business (2021-2026) & (US$ Million) Table 118. NxGen MDx Genetic Screening for Carrier Diseases Product Portfolio Table 119. NxGen MDx Recent Developments Table 120. Sonic Genetics Company Information Table 121. Sonic Genetics Business Overview Table 122. Sonic Genetics Revenue in Genetic Screening for Carrier Diseases Business (2021-2026) & (US$ Million) Table 123. Sonic Genetics Genetic Screening for Carrier Diseases Product Portfolio Table 124. Sonic Genetics Recent Developments Table 125. My Baby Company Information Table 126. My Baby Business Overview Table 127. My Baby Revenue in Genetic Screening for Carrier Diseases Business (2021-2026) & (US$ Million) Table 128. My Baby Genetic Screening for Carrier Diseases Product Portfolio Table 129. My Baby Recent Developments Table 130. AncestryDNA Company Information Table 131. AncestryDNA Business Overview Table 132. AncestryDNA Revenue in Genetic Screening for Carrier Diseases Business (2021-2026) & (US$ Million) Table 133. AncestryDNA Genetic Screening for Carrier Diseases Product Portfolio Table 134. AncestryDNA Recent Developments Table 135. DiaSorin Company Information Table 136. DiaSorin Business Overview Table 137. DiaSorin Revenue in Genetic Screening for Carrier Diseases Business (2021-2026) & (US$ Million) Table 138. DiaSorin Genetic Screening for Carrier Diseases Product Portfolio Table 139. DiaSorin Recent Developments Table 140. Grifols Company Information Table 141. Grifols Business Overview Table 142. Grifols Revenue in Genetic Screening for Carrier Diseases Business (2021-2026) & (US$ Million) Table 143. Grifols Genetic Screening for Carrier Diseases Product Portfolio Table 144. Grifols Recent Developments Table 145. BGI Genomics Company Information Table 146. BGI Genomics Business Overview Table 147. BGI Genomics Revenue in Genetic Screening for Carrier Diseases Business (2021-2026) & (US$ Million) Table 148. BGI Genomics Genetic Screening for Carrier Diseases Product Portfolio Table 149. BGI Genomics Recent Developments Table 150. Chigene Company Information Table 151. Chigene Business Overview Table 152. Chigene Revenue in Genetic Screening for Carrier Diseases Business (2021-2026) & (US$ Million) Table 153. Chigene Genetic Screening for Carrier Diseases Product Portfolio Table 154. Chigene Recent Developments Table 155. Jiajian Medical Testing Company Information Table 156. Jiajian Medical Testing Business Overview Table 157. Jiajian Medical Testing Revenue in Genetic Screening for Carrier Diseases Business (2021-2026) & (US$ Million) Table 158. Jiajian Medical Testing Genetic Screening for Carrier Diseases Product Portfolio Table 159. Jiajian Medical Testing Recent Developments Table 160. Genesky Company Information Table 161. Genesky Business Overview Table 162. Genesky Revenue in Genetic Screening for Carrier Diseases Business (2021-2026) & (US$ Million) Table 163. Genesky Genetic Screening for Carrier Diseases Product Portfolio Table 164. Genesky Recent Developments Table 165. Berry Genomics Company Information Table 166. Berry Genomics Business Overview Table 167. Berry Genomics Revenue in Genetic Screening for Carrier Diseases Business (2021-2026) & (US$ Million) Table 168. Berry Genomics Genetic Screening for Carrier Diseases Product Portfolio Table 169. Berry Genomics Recent Developments Table 170. Weihansi Biomedical Technology Company Information Table 171. Weihansi Biomedical Technology Business Overview Table 172. Weihansi Biomedical Technology Revenue in Genetic Screening for Carrier Diseases Business (2021-2026) & (US$ Million) Table 173. Weihansi Biomedical Technology Genetic Screening for Carrier Diseases Product Portfolio Table 174. Weihansi Biomedical Technology Recent Developments Table 175. Annaroad Company Information Table 176. Annaroad Business Overview Table 177. Annaroad Revenue in Genetic Screening for Carrier Diseases Business (2021-2026) & (US$ Million) Table 178. Annaroad Genetic Screening for Carrier Diseases Product Portfolio Table 179. Annaroad Recent Developments Table 180. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Genetic Screening for Carrier Diseases Product Image Figure 5. Global Genetic Screening for Carrier Diseases Market Size Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 6. Global Genetic Screening for Carrier Diseases Market Share by Type: 2025 VS 2032 Figure 7. NGS Product Figure 8. Whole Exome Sequencing Product Figure 9. Others Product Figure 10. Global Genetic Screening for Carrier Diseases Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Genetic Screening for Carrier Diseases Market Share by Application: 2025 VS 2032 Figure 12. Couple Product Figure 13. Individual Product Figure 14. Global Genetic Screening for Carrier Diseases Market Size (US$ Million), Year-over-Year: 2021-2032 Figure 15. Global Genetic Screening for Carrier Diseases Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Genetic Screening for Carrier Diseases Market Share by Region: 2025 VS 2032 Figure 17. Global Genetic Screening for Carrier Diseases Market Share by Players in 2025 Figure 18. Global Genetic Screening for Carrier Diseases Manufacturers Established Date Figure 19. Global Top 5 and 10 Genetic Screening for Carrier Diseases Players Market Share by Revenue in 2025 Figure 20. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. North America Genetic Screening for Carrier Diseases Market Size YoY Growth (2021-2032) & (US$ Million) Figure 22. North America Genetic Screening for Carrier Diseases Market Share by Country (2021-2032) Figure 23. United States Genetic Screening for Carrier Diseases Market Size YoY Growth (2021-2032) & (US$ Million) Figure 24. Canada Genetic Screening for Carrier Diseases Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Mexico Genetic Screening for Carrier Diseases Market Share by Country (2021-2032) Figure 26. Europe Genetic Screening for Carrier Diseases Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Europe Genetic Screening for Carrier Diseases Market Share by Country (2021-2032) Figure 28. Germany Genetic Screening for Carrier Diseases Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. France Genetic Screening for Carrier Diseases Market Size YoY Growth (2021-2032) & (US$ Million) Figure 30. U.K. Genetic Screening for Carrier Diseases Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Italy Genetic Screening for Carrier Diseases Market Size YoY Growth (2021-2032) & (US$ Million) Figure 32. Spain Genetic Screening for Carrier Diseases Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Russia Genetic Screening for Carrier Diseases Market Size YoY Growth (2021-2032) & (US$ Million) Figure 34. Netherlands Genetic Screening for Carrier Diseases Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Nordic Countries Genetic Screening for Carrier Diseases Market Size YoY Growth (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Genetic Screening for Carrier Diseases Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Genetic Screening for Carrier Diseases Market Share by Country (2021-2032) Figure 38. China Genetic Screening for Carrier Diseases Market Size YoY Growth (2021-2032) & (US$ Million) Figure 39. Japan Genetic Screening for Carrier Diseases Market Size YoY Growth (2021-2032) & (US$ Million) Figure 40. South Korea Genetic Screening for Carrier Diseases Market Size YoY Growth (2021-2032) & (US$ Million) Figure 41. India Genetic Screening for Carrier Diseases Market Size YoY Growth (2021-2032) & (US$ Million) Figure 42. India Genetic Screening for Carrier Diseases Market Share by Country (2021-2032) Figure 43. Australia Genetic Screening for Carrier Diseases Market Size YoY Growth (2021-2032) & (US$ Million) Figure 44. China Taiwan Genetic Screening for Carrier Diseases Market Size YoY Growth (2021-2032) & (US$ Million) Figure 45. Southeast Asia Genetic Screening for Carrier Diseases Market Size YoY Growth (2021-2032) & (US$ Million) Figure 46. South America Genetic Screening for Carrier Diseases Market Size YoY Growth (2021-2032) & (US$ Million) Figure 47. South America Genetic Screening for Carrier Diseases Market Share by Country (2021-2032) Figure 48. Brazil Genetic Screening for Carrier Diseases Market Size YoY Growth (2021-2032) & (US$ Million) Figure 49. Argentina Genetic Screening for Carrier Diseases Market Size YoY Growth (2021-2032) & (US$ Million) Figure 50. Chile Genetic Screening for Carrier Diseases Market Size YoY Growth (2021-2032) & (US$ Million) Figure 51. Colombia Genetic Screening for Carrier Diseases Market Size YoY Growth (2021-2032) & (US$ Million) Figure 52. Peru Genetic Screening for Carrier Diseases Market Size YoY Growth (2021-2032) & (US$ Million) Figure 53. Thermo Fisher Scientific Revenue Growth Rate in Genetic Screening for Carrier Diseases Business (2021-2026) Figure 54. Eurofins Scientific Revenue Growth Rate in Genetic Screening for Carrier Diseases Business (2021-2026) Figure 55. Illumina Revenue Growth Rate in Genetic Screening for Carrier Diseases Business (2021-2026) Figure 56. Invitae Revenue Growth Rate in Genetic Screening for Carrier Diseases Business (2021-2026) Figure 57. MedGenome Revenue Growth Rate in Genetic Screening for Carrier Diseases Business (2021-2026) Figure 58. Myriad Genetics Revenue Growth Rate in Genetic Screening for Carrier Diseases Business (2021-2026) Figure 59. Roche Revenue Growth Rate in Genetic Screening for Carrier Diseases Business (2021-2026) Figure 60. Natera Revenue Growth Rate in Genetic Screening for Carrier Diseases Business (2021-2026) Figure 61. OPKO Health Revenue Growth Rate in Genetic Screening for Carrier Diseases Business (2021-2026) Figure 62. 23andMe Revenue Growth Rate in Genetic Screening for Carrier Diseases Business (2021-2026) Figure 63. bioMérieux Revenue Growth Rate in Genetic Screening for Carrier Diseases Business (2021-2026) Figure 64. EKF Diagnostics Revenue Growth Rate in Genetic Screening for Carrier Diseases Business (2021-2026) Figure 65. Gene by Gene (myDNA) Revenue Growth Rate in Genetic Screening for Carrier Diseases Business (2021-2026) Figure 66. Fulgent Genetics Revenue Growth Rate in Genetic Screening for Carrier Diseases Business (2021-2026) Figure 67. NxGen MDx Revenue Growth Rate in Genetic Screening for Carrier Diseases Business (2021-2026) Figure 68. Sonic Genetics Revenue Growth Rate in Genetic Screening for Carrier Diseases Business (2021-2026) Figure 69. My Baby Revenue Growth Rate in Genetic Screening for Carrier Diseases Business (2021-2026) Figure 70. AncestryDNA Revenue Growth Rate in Genetic Screening for Carrier Diseases Business (2021-2026) Figure 71. DiaSorin Revenue Growth Rate in Genetic Screening for Carrier Diseases Business (2021-2026) Figure 72. Grifols Revenue Growth Rate in Genetic Screening for Carrier Diseases Business (2021-2026) Figure 73. BGI Genomics Revenue Growth Rate in Genetic Screening for Carrier Diseases Business (2021-2026) Figure 74. Chigene Revenue Growth Rate in Genetic Screening for Carrier Diseases Business (2021-2026) Figure 75. Jiajian Medical Testing Revenue Growth Rate in Genetic Screening for Carrier Diseases Business (2021-2026) Figure 76. Genesky Revenue Growth Rate in Genetic Screening for Carrier Diseases Business (2021-2026) Figure 77. Berry Genomics Revenue Growth Rate in Genetic Screening for Carrier Diseases Business (2021-2026) Figure 78. Weihansi Biomedical Technology Revenue Growth Rate in Genetic Screening for Carrier Diseases Business (2021-2026) Figure 79. Annaroad Revenue Growth Rate in Genetic Screening for Carrier Diseases Business (2021-2026)

Scope & coverage.

Types
  • NGS
  • Whole Exome Sequencing
  • Others
Applications
  • Couple
  • Individual
Companies covered
  • Thermo Fisher Scientific
  • Eurofins Scientific
  • Illumina
  • Invitae
  • MedGenome
  • Myriad Genetics
  • Roche
  • Natera
  • OPKO Health
  • 23andMe
  • bioMérieux
  • EKF Diagnostics
  • Gene by Gene (myDNA)
  • Fulgent Genetics
  • NxGen MDx
  • Sonic Genetics
  • My Baby
  • AncestryDNA
  • DiaSorin
  • Grifols
  • BGI Genomics
  • Chigene
  • Jiajian Medical Testing
  • Genesky
  • Berry Genomics
  • Weihansi Biomedical Technology
  • Annaroad

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Genetic Screening for Carrier Diseases by Type
  3. 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
  4. 2.2.2 NGS
  5. 2.2.3 Whole Exome Sequencing
  6. 2.2.4 Others
  7. 2.3 Genetic Screening for Carrier Diseases by Application
  8. 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  9. 2.3.2 Couple
  10. 2.3.3 Individual
  11. 2.4 Assumptions and Limitations
3 Genetic Screening for Carrier Diseases Breakdown Data by Type
  1. 3.1 Global Genetic Screening for Carrier Diseases Historic Market Size by Type (2021-2026)
  2. 3.2 Global Genetic Screening for Carrier Diseases Forecasted Market Size by Type (2027-2032)
4 Genetic Screening for Carrier Diseases Breakdown Data by Application
  1. 4.1 Global Genetic Screening for Carrier Diseases Historic Market Size by Application (2021-2026)
  2. 4.2 Global Genetic Screening for Carrier Diseases Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
  1. 5.1 Global Genetic Screening for Carrier Diseases Market Perspective (2021-2032)
  2. 5.2 Global Genetic Screening for Carrier Diseases Growth Trends by Region
  3. 5.2.1 Global Genetic Screening for Carrier Diseases Market Size by Region: 2021 VS 2025 VS 2032
  4. 5.2.2 Genetic Screening for Carrier Diseases Historic Market Size by Region (2021-2026)
  5. 5.2.3 Genetic Screening for Carrier Diseases Forecasted Market Size by Region (2027-2032)
  6. 5.3 Genetic Screening for Carrier Diseases Market Dynamics
  7. 5.3.1 Genetic Screening for Carrier Diseases Industry Trends
  8. 5.3.2 Genetic Screening for Carrier Diseases Market Drivers
  9. 5.3.3 Genetic Screening for Carrier Diseases Market Challenges
  10. 5.3.4 Genetic Screening for Carrier Diseases Market Restraints
6 Market Competitive Landscape by Players
  1. 6.1 Global Top Genetic Screening for Carrier Diseases Players by Revenue
  2. 6.1.1 Global Top Genetic Screening for Carrier Diseases Players by Revenue (2021-2026)
  3. 6.1.2 Global Genetic Screening for Carrier Diseases Revenue Market Share by Players (2021-2026)
  4. 6.2 Global Genetic Screening for Carrier Diseases Industry Players Ranking, 2023 VS 2024 VS 2025
  5. 6.3 Global Key Players of Genetic Screening for Carrier Diseases Head Office and Area Served
  6. 6.4 Global Genetic Screening for Carrier Diseases Players, Product Type & Application
  7. 6.5 Global Genetic Screening for Carrier Diseases Manufacturers Established Date
  8. 6.6 Global Genetic Screening for Carrier Diseases Market CR5 and HHI
  9. 6.7 Global Players Mergers & Acquisition
7 North America
  1. 7.1 North America Genetic Screening for Carrier Diseases Market Size (2021-2032)
  2. 7.2 North America Genetic Screening for Carrier Diseases Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 7.3 North America Genetic Screening for Carrier Diseases Market Size by Country (2021-2026)
  4. 7.4 North America Genetic Screening for Carrier Diseases Market Size by Country (2027-2032)
  5. 7.5 United States
  6. 7.5 United States
  7. 7.6 Canada
  8. 7.7 Mexico
8 Europe
  1. 8.1 Europe Genetic Screening for Carrier Diseases Market Size (2021-2032)
  2. 8.2 Europe Genetic Screening for Carrier Diseases Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 8.3 Europe Genetic Screening for Carrier Diseases Market Size by Country (2021-2026)
  4. 8.4 Europe Genetic Screening for Carrier Diseases Market Size by Country (2027-2032)
  5. 8.5 Germany
  6. 8.6 France
  7. 8.7 U.K.
  8. 8.8 Italy
  9. 8.9 Spain
  10. 8.10 Russia
  11. 8.11 Netherlands
  12. 8.12 Nordic Countries
9 Asia-Pacific
  1. 9.1 Asia-Pacific Genetic Screening for Carrier Diseases Market Size (2021-2032)
  2. 9.2 Asia-Pacific Genetic Screening for Carrier Diseases Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 9.3 Asia-Pacific Genetic Screening for Carrier Diseases Market Size by Country (2021-2026)
  4. 9.4 Asia-Pacific Genetic Screening for Carrier Diseases Market Size by Country (2027-2032)
  5. 9.5 China
  6. 9.6 Japan
  7. 9.7 South Korea
  8. 9.8 India
  9. 9.9 Australia
  10. 9.10 China Taiwan
  11. 9.11 Southeast Asia
10 South America
  1. 10.1 South America Genetic Screening for Carrier Diseases Market Size (2021-2032)
  2. 10.2 South America Genetic Screening for Carrier Diseases Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 10.3 South America Genetic Screening for Carrier Diseases Market Size by Country (2021-2026)
  4. 10.4 South America Genetic Screening for Carrier Diseases Market Size by Country (2027-2032)
  5. 10.5 Brazil
  6. 10.6 Argentina
  7. 10.7 Chile
  8. 10.8 Colombia
  9. 10.9 Peru
11 Middle East & Africa
  1. 11.1 Middle East & Africa Genetic Screening for Carrier Diseases Market Size (2021-2032)
  2. 11.2 Middle East & Africa Genetic Screening for Carrier Diseases Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 11.3 Middle East & Africa Genetic Screening for Carrier Diseases Market Size by Country (2021-2026)
  4. 11.4 Middle East & Africa Genetic Screening for Carrier Diseases Market Size by Country (2027-2032)
  5. 11.5 Saudi Arabia
  6. 11.6 Israel
  7. 11.7 United Arab Emirates
  8. 11.8 Turkey
  9. 11.9 Iran
  10. 11.10 Egypt
12 Players Profiled
  1. 12.1 Thermo Fisher Scientific
  2. 12.1.1 Thermo Fisher Scientific Company Information
  3. 12.1.2 Thermo Fisher Scientific Business Overview
  4. 12.1.3 Thermo Fisher Scientific Revenue in Genetic Screening for Carrier Diseases Business (2021-2026)
  5. 12.1.4 Thermo Fisher Scientific Genetic Screening for Carrier Diseases Product Portfolio
  6. 12.1.5 Thermo Fisher Scientific Recent Developments
  7. 12.2 Eurofins Scientific
  8. 12.2.1 Eurofins Scientific Company Information
  9. 12.2.2 Eurofins Scientific Business Overview
  10. 12.2.3 Eurofins Scientific Revenue in Genetic Screening for Carrier Diseases Business (2021-2026)
  11. 12.2.4 Eurofins Scientific Genetic Screening for Carrier Diseases Product Portfolio
  12. 12.2.5 Eurofins Scientific Recent Developments
  13. 12.3 Illumina
  14. 12.3.1 Illumina Company Information
  15. 12.3.2 Illumina Business Overview
  16. 12.3.3 Illumina Revenue in Genetic Screening for Carrier Diseases Business (2021-2026)
  17. 12.3.4 Illumina Genetic Screening for Carrier Diseases Product Portfolio
  18. 12.3.5 Illumina Recent Developments
  19. 12.4 Invitae
  20. 12.4.1 Invitae Company Information
  21. 12.4.2 Invitae Business Overview
  22. 12.4.3 Invitae Revenue in Genetic Screening for Carrier Diseases Business (2021-2026)
  23. 12.4.4 Invitae Genetic Screening for Carrier Diseases Product Portfolio
  24. 12.4.5 Invitae Recent Developments
  25. 12.5 MedGenome
  26. 12.5.1 MedGenome Company Information
  27. 12.5.2 MedGenome Business Overview
  28. 12.5.3 MedGenome Revenue in Genetic Screening for Carrier Diseases Business (2021-2026)
  29. 12.5.4 MedGenome Genetic Screening for Carrier Diseases Product Portfolio
  30. 12.5.5 MedGenome Recent Developments
  31. 12.6 Myriad Genetics
  32. 12.6.1 Myriad Genetics Company Information
  33. 12.6.2 Myriad Genetics Business Overview
  34. 12.6.3 Myriad Genetics Revenue in Genetic Screening for Carrier Diseases Business (2021-2026)
  35. 12.6.4 Myriad Genetics Genetic Screening for Carrier Diseases Product Portfolio
  36. 12.6.5 Myriad Genetics Recent Developments
  37. 12.7 Roche
  38. 12.7.1 Roche Company Information
  39. 12.7.2 Roche Business Overview
  40. 12.7.3 Roche Revenue in Genetic Screening for Carrier Diseases Business (2021-2026)
  41. 12.7.4 Roche Genetic Screening for Carrier Diseases Product Portfolio
  42. 12.7.5 Roche Recent Developments
  43. 12.8 Natera
  44. 12.8.1 Natera Company Information
  45. 12.8.2 Natera Business Overview
  46. 12.8.3 Natera Revenue in Genetic Screening for Carrier Diseases Business (2021-2026)
  47. 12.8.4 Natera Genetic Screening for Carrier Diseases Product Portfolio
  48. 12.8.5 Natera Recent Developments
  49. 12.9 OPKO Health
  50. 12.9.1 OPKO Health Company Information
  51. 12.9.2 OPKO Health Business Overview
  52. 12.9.3 OPKO Health Revenue in Genetic Screening for Carrier Diseases Business (2021-2026)
  53. 12.9.4 OPKO Health Genetic Screening for Carrier Diseases Product Portfolio
  54. 12.9.5 OPKO Health Recent Developments
  55. 12.10 23andMe
  56. 12.10.1 23andMe Company Information
  57. 12.10.2 23andMe Business Overview
  58. 12.10.3 23andMe Revenue in Genetic Screening for Carrier Diseases Business (2021-2026)
  59. 12.10.4 23andMe Genetic Screening for Carrier Diseases Product Portfolio
  60. 12.10.5 23andMe Recent Developments
  61. 12.11 bioMérieux
  62. 12.11.1 bioMérieux Company Information
  63. 12.11.2 bioMérieux Business Overview
  64. 12.11.3 bioMérieux Revenue in Genetic Screening for Carrier Diseases Business (2021-2026)
  65. 12.11.4 bioMérieux Genetic Screening for Carrier Diseases Product Portfolio
  66. 12.11.5 bioMérieux Recent Developments
  67. 12.12 EKF Diagnostics
  68. 12.12.1 EKF Diagnostics Company Information
  69. 12.12.2 EKF Diagnostics Business Overview
  70. 12.12.3 EKF Diagnostics Revenue in Genetic Screening for Carrier Diseases Business (2021-2026)
  71. 12.12.4 EKF Diagnostics Genetic Screening for Carrier Diseases Product Portfolio
  72. 12.12.5 EKF Diagnostics Recent Developments
  73. 12.13 Gene by Gene (myDNA)
  74. 12.13.1 Gene by Gene (myDNA) Company Information
  75. 12.13.2 Gene by Gene (myDNA) Business Overview
  76. 12.13.3 Gene by Gene (myDNA) Revenue in Genetic Screening for Carrier Diseases Business (2021-2026)
  77. 12.13.4 Gene by Gene (myDNA) Genetic Screening for Carrier Diseases Product Portfolio
  78. 12.13.5 Gene by Gene (myDNA) Recent Developments
  79. 12.14 Fulgent Genetics
  80. 12.14.1 Fulgent Genetics Company Information
  81. 12.14.2 Fulgent Genetics Business Overview
  82. 12.14.3 Fulgent Genetics Revenue in Genetic Screening for Carrier Diseases Business (2021-2026)
  83. 12.14.4 Fulgent Genetics Genetic Screening for Carrier Diseases Product Portfolio
  84. 12.14.5 Fulgent Genetics Recent Developments
  85. 12.15 NxGen MDx
  86. 12.15.1 NxGen MDx Company Information
  87. 12.15.2 NxGen MDx Business Overview
  88. 12.15.3 NxGen MDx Revenue in Genetic Screening for Carrier Diseases Business (2021-2026)
  89. 12.15.4 NxGen MDx Genetic Screening for Carrier Diseases Product Portfolio
  90. 12.15.5 NxGen MDx Recent Developments
  91. 12.16 Sonic Genetics
  92. 12.16.1 Sonic Genetics Company Information
  93. 12.16.2 Sonic Genetics Business Overview
  94. 12.16.3 Sonic Genetics Revenue in Genetic Screening for Carrier Diseases Business (2021-2026)
  95. 12.16.4 Sonic Genetics Genetic Screening for Carrier Diseases Product Portfolio
  96. 12.16.5 Sonic Genetics Recent Developments
  97. 12.17 My Baby
  98. 12.17.1 My Baby Company Information
  99. 12.17.2 My Baby Business Overview
  100. 12.17.3 My Baby Revenue in Genetic Screening for Carrier Diseases Business (2021-2026)
  101. 12.17.4 My Baby Genetic Screening for Carrier Diseases Product Portfolio
  102. 12.17.5 My Baby Recent Developments
  103. 12.18 AncestryDNA
  104. 12.18.1 AncestryDNA Company Information
  105. 12.18.2 AncestryDNA Business Overview
  106. 12.18.3 AncestryDNA Revenue in Genetic Screening for Carrier Diseases Business (2021-2026)
  107. 12.18.4 AncestryDNA Genetic Screening for Carrier Diseases Product Portfolio
  108. 12.18.5 AncestryDNA Recent Developments
  109. 12.19 DiaSorin
  110. 12.19.1 DiaSorin Company Information
  111. 12.19.2 DiaSorin Business Overview
  112. 12.19.3 DiaSorin Revenue in Genetic Screening for Carrier Diseases Business (2021-2026)
  113. 12.19.4 DiaSorin Genetic Screening for Carrier Diseases Product Portfolio
  114. 12.19.5 DiaSorin Recent Developments
  115. 12.20 Grifols
  116. 12.20.1 Grifols Company Information
  117. 12.20.2 Grifols Business Overview
  118. 12.20.3 Grifols Revenue in Genetic Screening for Carrier Diseases Business (2021-2026)
  119. 12.20.4 Grifols Genetic Screening for Carrier Diseases Product Portfolio
  120. 12.20.5 Grifols Recent Developments
  121. 12.21 BGI Genomics
  122. 12.21.1 BGI Genomics Company Information
  123. 12.21.2 BGI Genomics Business Overview
  124. 12.21.3 BGI Genomics Revenue in Genetic Screening for Carrier Diseases Business (2021-2026)
  125. 12.21.4 BGI Genomics Genetic Screening for Carrier Diseases Product Portfolio
  126. 12.21.5 BGI Genomics Recent Developments
  127. 12.22 Chigene
  128. 12.22.1 Chigene Company Information
  129. 12.22.2 Chigene Business Overview
  130. 12.22.3 Chigene Revenue in Genetic Screening for Carrier Diseases Business (2021-2026)
  131. 12.22.4 Chigene Genetic Screening for Carrier Diseases Product Portfolio
  132. 12.22.5 Chigene Recent Developments
  133. 12.23 Jiajian Medical Testing
  134. 12.23.1 Jiajian Medical Testing Company Information
  135. 12.23.2 Jiajian Medical Testing Business Overview
  136. 12.23.3 Jiajian Medical Testing Revenue in Genetic Screening for Carrier Diseases Business (2021-2026)
  137. 12.23.4 Jiajian Medical Testing Genetic Screening for Carrier Diseases Product Portfolio
  138. 12.23.5 Jiajian Medical Testing Recent Developments
  139. 12.24 Genesky
  140. 12.24.1 Genesky Company Information
  141. 12.24.2 Genesky Business Overview
  142. 12.24.3 Genesky Revenue in Genetic Screening for Carrier Diseases Business (2021-2026)
  143. 12.24.4 Genesky Genetic Screening for Carrier Diseases Product Portfolio
  144. 12.24.5 Genesky Recent Developments
  145. 12.25 Berry Genomics
  146. 12.25.1 Berry Genomics Company Information
  147. 12.25.2 Berry Genomics Business Overview
  148. 12.25.3 Berry Genomics Revenue in Genetic Screening for Carrier Diseases Business (2021-2026)
  149. 12.25.4 Berry Genomics Genetic Screening for Carrier Diseases Product Portfolio
  150. 12.25.5 Berry Genomics Recent Developments
  151. 12.26 Weihansi Biomedical Technology
  152. 12.26.1 Weihansi Biomedical Technology Company Information
  153. 12.26.2 Weihansi Biomedical Technology Business Overview
  154. 12.26.3 Weihansi Biomedical Technology Revenue in Genetic Screening for Carrier Diseases Business (2021-2026)
  155. 12.26.4 Weihansi Biomedical Technology Genetic Screening for Carrier Diseases Product Portfolio
  156. 12.26.5 Weihansi Biomedical Technology Recent Developments
  157. 12.27 Annaroad
  158. 12.27.1 Annaroad Company Information
  159. 12.27.2 Annaroad Business Overview
  160. 12.27.3 Annaroad Revenue in Genetic Screening for Carrier Diseases Business (2021-2026)
  161. 12.27.4 Annaroad Genetic Screening for Carrier Diseases Product Portfolio
  162. 12.27.5 Annaroad Recent Developments
13 Report Conclusion
    14 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst